GSK plc
- September 12th, 2024
$1 billion in cost cuts, 10 product launches planned – MASHAHER
- September 10th, 2024
Veteran investor names are 5 ‘well-run’ Indian companies he likes – MASHAHER
- August 1st, 2024
Moderna (MRNA) earnings Q2 2024 – MASHAHER
- June 27th, 2024
Stocks making the biggest moves premarket: WBA, LEVI, MU – MASHAHER
- June 17th, 2024
FDA approves Merck pneumococcal disease vaccine designed for adults – MASHAHER
- June 8th, 2024
FDA approves GSK RSV vaccine for adults 50 to 59 – MASHAHER
- May 31st, 2024
FDA approves Moderna RSV vaccine for seniors – MASHAHER
- February 27th, 2024
GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons – MASHAHER
- February 20th, 2024
Morningstar strategist names 3 under-the radar stocks – MASHAHER